跳至主要内容
临床试验/DRKS00005456
DRKS00005456招募中不适用

on-interventional study about the tolerability and efficacy of chemotherapy with Oxaliplatin (Euroxaliplatin(R)) in everday use for treatment of the colorectal carcinoma - ABC-Study/002

apharm GmbH0 个研究点目标入组 500 人开始时间: 2014年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Histologically confirmed colorectal carcinoma
  • Age: = 18 years
  • Signed informed consent
  • Capacity of the patient to consent (knowledge of manner, significance and consequences of medical operations)
  • Adequate pregnancy prevention measures during the cytostatic therapy
  • Therapy in an oncological doctors practice

排除标准

  • Pregnancy (in female patients)
  • Period of lactation (in female patients)

研究者

发起方
apharm GmbH

相似试验